Founded in 2007, Klea Holding is a group focused on acquiring, developing and digitizing companies in various sectors to maximize their growth and value. Through its "scaling industries of the future" identity, Klea Holding draws on its successful experience in developing Smart Salem, the first network of digitalized medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the United Arab Emirates, its joint venture Smart Health, dedicated to the roll-out of digital medical testing centres in Saudi Arabia; and Klea Pharmaceuticals, a subsidiary dedicated to the commercialisation of a portfolio of licensed medicines in the Middle East and Africa.

Employees

128

Sector

Healthcare Facilities & Services

More about the company

Quotes

Date	Price	Change	Volume
07/07/26	EUR 0.1800	-0.44%	38,468
06/07/26	EUR 0.1808	+1.01%	44,208
03/07/26	EUR 0.1790	-2.61%	368,413
02/07/26	EUR 0.1838	+1.66%	56,553
01/07/26	EUR 0.1808	-1.42%	237,488

Real-time Euronext Paris

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Market Closed - Euronext Paris Other stock markets 01:55:00 08/07/26 am AEST			5-day change	1st Jan Change
0.1800 ^EUR	-0.44%		-1.85%	-17.81%

12/06	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI
11/06	Klea Launches Medicine Distribution Business for Middle East, Africa	MT

Market Cap	55.26M 63.04M 50.96M 47.2M 89.5M 5.99B 91.01M 611M 237M 2.95B 237M 231M 10.22B	P/E 2024	44.3x	P/E 2025	31.3x
Enterprise Value	55.38M 63.18M 51.07M 47.31M 89.7M 6B 91.22M 612M 238M 2.96B 237M 232M 10.25B	EV / Sales 2024	3.3x	EV / Sales 2025	3.04x
Free-Float	99.83%	Yield 2024 *	-	Yield 2025	-

12/06	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI
11/06	Klea Launches Medicine Distribution Business for Middle East, Africa	MT
11/06	Klea Holding announces the launch of its new subsidiary
24/04	Klea Holding SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
01/04	Klea Holding Establishes Klea Pharmaceuticals and Expands Healthcare Operations in Middle East and Africa	CI
01/04	Klea Holding SA acquired New Licences and Pharmaceutical Assets for AED 8.5 million.	CI
20/01	Klea Holding Increases Annual Revenue by 28%
19/01	Klea Holding SA Reports Unaudited Consolidated Sales Results for the Year Ended December 31, 2025	CI
19/01	Klea Holding SA to Open First Digital Medical Centre in Saudi Arabia in March/April 2026	CI
27/10/25	Klea Holding Strengthens Its Presence in Dubai with Its First Strategic Real Estate Investment in the Lumena Alta Project	CI
27/10/25	Klea Holding Buys Office Space at Skyscraper Project in Dubai	MT
19/09/25	Klea Holding SA Reports Earnings Results for the Half Year Ended June 30, 2025	CI
19/08/25	Klea Holding SA commences an Equity Buyback Plan for 30,751,431 shares, representing 10% of its issued share capital for ?46.13 million, under the authorization approved on June 10, 2025.	CI

11/06	Klea Holding : Klea Pharmaceuticals launch its business with a strong partner	AT
24/04	Klea : reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	PU
24/04	Klea Holding : Klea Holding reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	AT
01/04	Klea Holding : Klea Holding is accelerating its diversification into the healthcare sector with the creation of Klea Pharmaceuticals	AT
19/01	Klea Holding : Klea Holding reports profitable growth of 34% in turnover in 2025 at constant exchange rates	AT

Klea Holding Stock

Stocks

ALKLH

FR0013481835

Healthcare Facilities & Services

Valuation: Klea Holding

Chart: Klea Holding

Latest news : Klea Holding

Analysts' recommendations: Klea Holding

Press Releases: Klea Holding

News in other languages: Klea Holding

Quotes and Performance

Course Extremes

Managers and Directors: Klea Holding

Latest insider transactions

Other Healthcare Facilities & Services

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

07/07	Klea Holding : Déclaration des transactions sur actions propres
30/06	Klea Holding : Déclaration des transactions sur actions propres
13/06	Klea Holding : Déclaration des transactions sur actions propres
11/06	Bourse : J-1 avant SpaceX, Oracle à la peine, contrat pour Airbus
11/06	Klea Holding annonce le démarrage de sa nouvelle filiale

1 day	-0.44%
1 week	-1.85%
Current month	-1.85%
1 month	-3.54%
3 months	+1.58%
6 months	-21.40%
Current year	-17.81%

1 week	0.18	0.18
1 month	0.17	0.19
Current year	0.15	0.25
1 year	0.15	0.31
3 years	0.15	0.52
5 years	0.08	0.59
10 years	0.08	172.4

Manager	Title	Age	Since
Clement Pacaud CEO	Chief Executive Officer	36	22/01/2024
Jérôme Fabreguettes-Leib IRC	Investor Relations Contact	-	-
Thomas Picquette CEO	Chief Executive Officer	-	01/04/2022

Director	Title	Age	Since
Guillaume Bremond CHM	Chairman	-	-
Anne Gaignard BRD	Director/Board Member	-	01/04/2022
Paul Amsellem BRD	Director/Board Member	51	14/06/2023

Date	Insider	Type	Quantity	% Market Cap.
11/03	Raphael Smila	Buy	167,212	0.0544%
11/03	Raphael Smila	Buy	15,000	0.0049%
11/03	Raphael Smila	Buy	95,000	0.0309%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KLEA HOLDING	-0.44%	-1.85%	-0.11%	-64.04%	63.37M
CVS HEALTH CORPORATION	+2.20%	+0.85%	+56.46%	+50.83%	130B
HCA HEALTHCARE, INC.	+1.45%	+8.52%	+11.64%	+45.15%	92.52B
FRESENIUS SE & CO. KGAA	+0.49%	+8.61%	+2.31%	+76.18%	27.78B
QUEST DIAGNOSTICS INCORPORATED	-0.50%	+0.20%	+22.08%	+52.79%	23.63B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	-0.55%	+2.61%	-19.52%	-24.56%	20.29B
TENET HEALTHCARE CORPORATION	+1.28%	+11.62%	+20.64%	+160.83%	17.76B
DAVITA INC.	-0.59%	+5.32%	+64.07%	+125.54%	15.13B
REDE D'OR SÃO LUIZ S.A.	-0.49%	+0.35%	+1.75%	+10.08%	14.9B
FRESENIUS MEDICAL CARE AG	+2.67%	+6.79%	-11.79%	-1.38%	12.63B
Average	+0.55%	+4.40%	+14.75%	+43.14%	35.5B
Weighted average by Cap.	+1.27%	+4.48%	+27.71%	+52.26%

	2024	2025
Net sales	17.26M 19.69M 15.92M 14.74M 27.96M 1.87B 28.43M 191M 74.14M 923M 73.9M 72.29M 3.19B	22.17M 25.29M 20.44M 18.93M 35.9M 2.4B 36.51M 245M 95.21M 1.18B 94.91M 92.84M 4.1B
Net income	1.4M 1.6M 1.3M 1.2M 2.28M 152M 2.31M 15.53M 6.03M 75.1M 6.02M 5.88M 260M	2.28M 2.6M 2.1M 1.95M 3.69M 247M 3.76M 25.21M 9.8M 122M 9.77M 9.55M 422M
Net Debt	2.58M 2.94M 2.37M 2.2M 4.17M 279M 4.24M 28.46M 11.06M 138M 11.03M 10.78M 476M	125K 143K 115K 107K 202K 13.55M 206K 1.38M 537K 6.68M 535K 524K 23.12M